Announced in April 2024, the LG 21HQ613D is a new medical-use monitor approved by the United States Food and Drug Administration (FDA). As a professional product, it is guaranteed to be priced several times higher than comparable consumer monitors; in any case, no official price has yet been communicated to date.
Much like the 21HQ513D, a lower resolution 1536 x 2048 monitor that can currently be purchased on eBay for a whopping $4,923, the 21HQ613D boasts a high brightness of 1100 cd/m2 and a high contrast ratio of 1800:1. Although the PPI value of this new monitor is not particularly high (153.9), it supports several viewing modes, including those that allow certain parts of the image to be dimmed and others to be highlighted. in evidence. The figures for color space coverage are modest: 100% sRGB and 72% NTSC, which also corresponds to what is indicated on the site https://www.lg.com/us/ business/medical-monitors/lg-21hq513d#pdp_spec for the 21HQ513D.
The new LG monitor comes with a versatile stand that supports tilt, swivel, height, and swivel adjustments. It has five customizable keys for quickly adjusting important settings. It also has multiple DisplayPort and DVI inputs, with the necessary cables included in the box, as well as an external power brick.
Without a stand, the 21HQ613D weighs 5.45 kg and its dimensions are 364.5 x 474.4 x 78 mm. While the United States appears to be the main market for this product, some of these monitors could soon end up in hospitals in France as well as other countries.
